Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720
Authors
Keywords
Predictive biomarkers, PP2A, Therapeutic groups, Personalised medicine
Journal
EPMA Journal
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-01-25
DOI
10.1186/1878-5085-5-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
- (2013) Olga Golubnitschaja et al. EPMA Journal
- CIP2A Is a Predictor of Poor Prognosis in Colon Cancer
- (2012) Hao-Wei Teng et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Ensembl 2013
- (2012) Paul Flicek et al. NUCLEIC ACIDS RESEARCH
- CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes
- (2012) M Niemelä et al. ONCOGENE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
- (2012) Olga Golubnitschaja et al. EPMA Journal
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Prognostic role of CIP2A expression in serous ovarian cancer
- (2011) C Böckelman et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation
- (2011) J. WANG et al. International Journal of Laboratory Hematology
- Assessment of PTEN and PI3K Status in Primary Breast Cancer and Corresponding Metastases: Is It Worthwhile?
- (2011) Michelangelo Russillo et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Cancer-Associated Mutations in the A Subunit of Protein Phosphatase 2A Increase Lung Cancer Incidence in A Knock-In and Knockout Mice
- (2011) R. Ruediger et al. MOLECULAR AND CELLULAR BIOLOGY
- Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer
- (2011) Sampoorna Satheesha et al. Molecular Cancer
- Targeting the Akt/mTOR pathway in Brca1-deficient cancers
- (2011) T Xiang et al. ONCOGENE
- Silencing of the PP2A catalytic subunit causes HER-2/neu positive breast cancer cells to undergo apoptosis
- (2010) Lee Lee Wong et al. EXPERIMENTAL CELL RESEARCH
- CIP2A expression is increased in prostate cancer
- (2010) Markku H Vaarala et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy
- (2010) Stuart J Schnitt MODERN PATHOLOGY
- CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells
- (2010) K-F Chen et al. ONCOGENE
- Rapamycin Inhibits IGF-1 Stimulated Cell Motility through PP2A Pathway
- (2010) Lei Liu et al. PLoS One
- The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein
- (2010) Zhaohui Feng et al. TRENDS IN CELL BIOLOGY
- Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling
- (2009) Christina Gewinner et al. CANCER CELL
- The Complex Relationship between BRCA1 and ER in Hereditary Breast Cancer
- (2009) J. J. Gorski et al. CLINICAL CANCER RESEARCH
- CIP2A Is Associated with Human Breast Cancer Aggressivity
- (2009) C. Come et al. CLINICAL CANCER RESEARCH
- α4 Is an Essential Regulator of PP2A Phosphatase Activity
- (2009) Mei Kong et al. MOLECULAR CELL
- Igbp1 is part of a positive feedback loop in stem cell factor-dependent, selective mRNA translation initiation inhibiting erythroid differentiation
- (2008) G. Grech et al. BLOOD
- Negative Regulation of AKT Activation by BRCA1
- (2008) T. Xiang et al. CANCER RESEARCH
- Multiple pathways regulated by the tumor suppressor PP2A in transformation
- (2008) Jukka Westermarck et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More